A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Bitolterol
Isoxicam
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Isoxicam.
Bitolterol
Kebuzone
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Kebuzone.
Bitolterol
Salicylamide
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Salicylamide.
Bitolterol
Parecoxib
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Parecoxib.
Bitolterol
Azapropazone
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Azapropazone.
Bitolterol
Zaltoprofen
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Zaltoprofen.
Bitolterol
Lornoxicam
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Lornoxicam.
Bitolterol
Ceftaroline fosamil
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Ceftaroline fosamil.
Bitolterol
Cimicoxib
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Cimicoxib.
Bitolterol
Ceftobiprole
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Ceftobiprole.
Bitolterol
Zomepirac
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Zomepirac.
Bitolterol
Metamizole
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Metamizole.
Bitolterol
Benoxaprofen
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Benoxaprofen.
Bitolterol
Nimesulide
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Nimesulide.
Bitolterol
Latamoxef
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Latamoxef.
Bitolterol
Oxyphenbutazone
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Oxyphenbutazone.
Bitolterol
Cephalothin Group
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Cephalothin Group.
Bitolterol
Hydrolyzed Cephalothin
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Hydrolyzed Cephalothin.
Bitolterol
Etoricoxib
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Etoricoxib.
Bitolterol
Lopinavir
The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Lopinavir.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3